How Artificial Intelligence Platform BullFrog AI Aims To Advance Drug Research By Leaps And Bounds

Vin Singh, Founder & CEO of BullFrog AI BFRG, was recently a guest on Benzinga’s All-Access.

BullFrog is an artificial intelligence company that has developed AI technology it calls bfLEAP. The platform is designed to transform the field of precision medicine by applying predictive analytics to all stages of drug development. In doing so the company aims to improve the lives of every patient.

The company has just announced exciting data from a preclinical trial for a therapy targeting glioblastoma.

Watch the full interview here:

Featured photo by Robert Zunikoff on Unsplash.

This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.